Atacand Plus · DIN 02332922 · 32 mg & 12.5 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Atacand Plus · DIN 02332922
Manufacturer: Cheplapharm Arzneimittel GmbH; listing date 2010-07-20
Health Canada: Marketed since 2025-06-19 · brand ATACAND PLUS · ATC C09DA06 CANDERSARTAN AND DIURETICS, C09DA06 CANDERSARTAN AND DIURETICS · form Tablet · route Oral · ingredients HYDROCHLOROTHIAZIDE 12.5 MG, CANDESARTAN CILEXETIL 32 MG · company Cheplapharm arzneimittel gmbh · schedule Prescription
Ministry pays: $0.2156 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02332922)
Source record
DIN 02332922: Atacand Plus
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240800291; group id 315; item number 0697; lccId None; manufacturer id CHE
Source form: Tab; strength: 32mg & 12.5mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $1.6162; ministry $0.2156
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02332922
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81858
Interchangeable products
Auro-Candesartan HCT · DIN 02421046 · $0.2156
Candesartan/HCTZ · DIN 02536064 · $0.2156
Jamp Candesartan-HCT · DIN 02473259 · $0.2156
NRA-Candesartan HCTZ · DIN 02531259 · $0.2156
Sandoz Candesartan Plus · DIN 02420732 · $0.2156
Teva-Candesartan/HCTZ · DIN 02395568 · $0.2156
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02332922
Shortage record checked October 6, 2026